During investigations on the effect of caffeine on ibuprofen-induced gastri
c mucosal lesions in rats, we have found that caffeine (p.o.) inhibits the
development of ibuprofen-induced gastric lesions in a dose-dependent manner
(ED50 18.4 mg kg(-1)). To investigate this protective effect of caffeine,
we have studied the effect of caffeine on HCl-ethanol-induced gastric mucos
al lesions with or without indomethacin pretreatment.
Caffeine inhibited the development of HCl-ethanol-induced gastric lesions w
ith and without indomethacin pretreatment. These results indicate that caff
eine did not act as a mild irritant but, on the contrary, had protective ef
fects. We measured the gastric mucosal prostaglandin E-2 (PGE(2)) concentra
tions and gastric mucosal blood flow, as representative protective factors
for gastric mucosa. Caffeine did not affect the gastric mucosal PGE2 concen
trations 4 h after administration of ibuprofen. However, topical administra
tion of caffeine resulted in an increase in gastric mucosal blood flow, as
measured by laser Doppler flowmetry. We investigated the gastric acid secre
tion and gastric mucosal myeloperoxidase activity as representative aggress
ive factors for gastric mucosa. When caffeine was administered intraduodena
lly in pylorus-ligated rats, gastric acid secretion decreased in a dose-dep
endent manner, with an ED50 of 44.9 mg kg(-1). Caffeine decreased ibuprofen
-induced gastric myeloperoxidase activity in a dose-dependent manner, with
an ED50 of 9.1 mg kg(-1)
These findings indicate that caffeine, at least in rats, may inhibit the de
velopment of acute gastric mucosal injury. The mechanisms underlying the pr
otective actions of caffeine are unclear, but may be related in part to an
increase in gastric mucosal blood flow and suppression of neutrophil activa
tion.